FuelCell Energy Inc vs IDEXX Laboratories, Inc. — how do they compare? FuelCell Energy Inc trades at $19.58 (market cap $1.54B), while IDEXX Laboratories, Inc. trades at $590 (market cap $46.22B). The key difference: IDEXX Laboratories, Inc. is far larger — about 30× FuelCell Energy Inc's market cap, and FuelCell Energy Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| FCEL | IDXX | |
|---|---|---|
Market Cap | $1.54B | $46.22B |
Sector | Industrials | Health |
52-Week High | $36.01 | $766.68 |
52-Week Low | $3.92 | $526.44 |
Enterprise Value | $1.38B | $47.12B |
Signals from Pluang's Aura AI — not financial advice
FuelCell Energy (FCEL) trades at $19.83, down 2.94% on the day, with a bearish technical signal and negative profitability metrics. The company reported a net loss of $187.90 million on $158.16 million revenue for 2025, though it beat EPS estimates in two recent quarters. Recent news highlights partnerships with Siemens and AI-driven power demand opportunities, contributing to volatile stock performance.
Outlook remains speculative with high risk due to persistent losses and negative margins, offset by analyst optimism (45% buy rating) and a $20.75 consensus price target. Key risks include cash burn, competitive pressures, and execution challenges in scaling hydrogen technology.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
Read more on FCEL →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →